aminoimidazole carboxamide has been researched along with lometrexol in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (50.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Cherian, C; Gangjee, A; Hales, E; Hou, Z; Matherly, LH; Mitchell-Ryan, S; Orr, S; Raghavan, S; Ravindra, MP; Wang, Y | 1 |
| Beardsley, GP; Cashmore, AR; Moroson, BA; Pizzorno, G | 1 |
2 other study(ies) available for aminoimidazole carboxamide and lometrexol
| Article | Year |
|---|---|
Discovery of 5-substituted pyrrolo[2,3-d]pyrimidine antifolates as dual-acting inhibitors of glycinamide ribonucleotide formyltransferase and 5-aminoimidazole-4-carboxamide ribonucleotide formyltransferase in de novo purine nucleotide biosynthesis: implic
Topics: AMP-Activated Protein Kinases; Animals; Antineoplastic Agents; Apoptosis; Cell Proliferation; CHO Cells; Cricetulus; Dose-Response Relationship, Drug; Drug Discovery; Drug Screening Assays, Antitumor; Enzyme Inhibitors; Folic Acid Antagonists; Humans; Hydroxymethyl and Formyl Transferases; KB Cells; Models, Molecular; Molecular Structure; Purine Nucleotides; Pyrimidines; Pyrroles; Structure-Activity Relationship | 2013 |
(6R)-5,10-Dideaza-5,6,7,8-tetrahydrofolic acid effects on nucleotide metabolism in CCRF-CEM human T-lymphoblast leukemia cells.
Topics: Adenosine Triphosphate; Aminoimidazole Carboxamide; Cytidine Triphosphate; DNA; Folic Acid Antagonists; Guanosine Triphosphate; Humans; Hypoxanthine; Hypoxanthines; Leukemia-Lymphoma, Adult T-Cell; RNA; Tetrahydrofolates; Thymidylate Synthase; Time Factors; Tumor Cells, Cultured; Uridine Triphosphate | 1991 |